Nav: Home

Scientists unlock path to use cell's own nanoparticles as disease biomarkers

April 12, 2018

Researchers at the University of Sydney have established a method to identify individual nanoparticles released by human cells, opening the way for them to become diagnostic tools in the early-detection of cancers, dementia and kidney disease.

The particles, known as extracellular vesicles, or EVs, are routinely released by cells and play a central role in cell communication, sharing vital information such as DNA, RNA and proteins.

"This really is at the cutting edge of our knowledge of cellular development," said Associate Professor Wojciech Chrzanowski, co-author of a new paper on EVs published in the Royal Society of Chemistry's Nanoscale Horizons.

"EVs could not only be used to identify cellular pathologies but because they carry essential information about cell development, we could engineer them for purposes of tissue repair."

Associate Professor Chrzanowski from the University of Sydney Nano Institute and the Faculty of Pharmacy said the ability to identify individual EVs will provide biomarkers for diverse diseases such as cancers, cardiovascular, kidney and liver disease as well as dementia and multiple sclerosis.

He said it will also allow scientists to engineer EVs for use in tissue regeneration and help start a new chapter in stem-cell therapies and regenerative medicine.

"The human body naturally directs EVs from stem cells to damaged tissue to assist in its repair. By harnessing this knowledge, we could create a new generation of cell therapies," said Associate Professor Chrzanowski, who is the industry theme leader for Health and Medicine at Sydney Nano.

Understanding the particular nature of EVs is therefore essential for developing their application for diagnostics and therapeutics. For instance, early-stage cancerous cells release EVs that indicate the presence of malignant tissue in the body.

The study of extracellular vesicles is a relatively new field. It is only in the past decade that it has been known that cells communicate and transfer molecular and genetic information using EVs.

The full potential to harness this knowledge for biomedical use has been hampered due to difficulties in establishing the heterogeneous nature of EV populations. Until now, they have only been analysed as large-scale populations with insufficient sensitivity.

Lead author of the paper, doctoral candidate Sally Yunsun Kim, said: "To unlock the true potential of EVs, what is needed is a new approach to unequivocally define nanoscale differences at a single EV level - and that is what we have done."

This is because it is the individual nature of the EVs as released by cells - affected by cellular morphology, genetics and environment - that give them their agency in human tissue repair.

Ms Kim, Associate Professor Chrzanowski and their team have developed a way to identify individual EV nanostructures, through examination of human placental stem cells provided by co-author Dr Bill Kalionis from the Royal Women's Hospital in Melbourne.

In the Nanoscale Horizons paper the team details a new method to identify the nanoscale composition of EVs using "resonance-enhanced atomic force microscope infrared spectroscopy" (AFM-IR).

This involves isolating singular EVs, thermally agitating them and then reading the particular signal or 'fingerprint' from this thermal activity using a 20-nanometre-wide detector.

Ms Kim, said: "We can do this using small amounts of human material, such as blood or urine samples. When cells create EVs they are spread throughout the body."

Associate Professor Chrzanowski said this ability to determine the particular nature of EVs will also allow scientists to continue fundamental research into how and why EVs are created by cells.

"This is a new and exciting field for biomedical research. And Australia is playing a leading role in this area," said Associate Professor Chrzanowski, who is a joint organiser of an international conference on extracellular vesicles that will take place in Sydney in November.

"The best people in the world will be here sharing their knowledge in a field with such promise for biomedical treatments," he said.
-end-


University of Sydney

Related Stem Cells Articles:

A protein that stem cells require could be a target in killing breast cancer cells
Researchers have identified a protein that must be present in order for mammary stem cells to perform their normal functions.
Approaching a decades-old goal: Making blood stem cells from patients' own cells
Researchers at Boston Children's Hospital have, for the first time, generated blood-forming stem cells in the lab using pluripotent stem cells, which can make virtually every cell type in the body.
New research finds novel method for generating airway cells from stem cells
Researchers have developed a new approach for growing and studying cells they hope one day will lead to curing lung diseases such as cystic fibrosis through 'personalized medicine.'
Mature heart muscle cells created in the laboratory from stem cells
Generating mature and viable heart muscle cells from human or other animal stem cells has proven difficult for biologists.
Mutations in bone cells can drive leukemia in neighboring stem cells
DNA mutations in bone cells that support blood development can drive leukemia formation in nearby blood stem cells.
Scientists take aging cardiac stem cells out of semiretirement to improve stem cell therapy
With age, the chromosomes of our cardiac stem cells compress as they move into a state of safe, semiretirement.
Purest yet liver-like cells generated from induced pluripotent stem cells
A team of researchers from the Medical University of South Carolina and elsewhere has found a better way to purify liver cells made from induced pluripotent stem cells.
Stem cell scientists discover genetic switch to increase supply of stem cells from cord blood
International stem cell scientists, co-led in Canada by Dr. John Dick and in the Netherlands by Dr.
Stem cells from diabetic patients coaxed to become insulin-secreting cells
Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St.

Related Stem Cells Reading:

Stem Cell Therapy: A Rising Tide: How Stem Cells Are Disrupting Medicine and Transforming Lives
by Neil H Riordan (Author)

Stem Cells: A Short Course
by Rob Burgess (Author)

The Science of Stem Cells
by Jonathan M. W. Slack (Author)

MSC (Mesenchymal Stem Cells): Clinical Evidence Leading Medicine's Next Frontier
by PA, PhD Neil H Riordan (Author), PhD Thomas Ichim (Author), Neil Riordan (Contributor)

Essentials of Stem Cell Biology
by Robert Lanza (Editor), Anthony Atala (Editor)

Stem Cells: An Insider's Guide
by Paul Knoepfler (Author)

Stem Cells For Dummies
by Lawrence S.B. Goldstein (Author), Meg Schneider (Author)

The Stem Cell Revolution
by Mark Berman MD (Author), Elliot Lander MD (Contributor)

Engineering Stem Cells for Tissue Regeneration
by Ngan F Huang (Author), Ngan F Huang (Editor), Nicolas L'Heureux (Editor), Song L (Editor)

Stem Cell Revolution: Discover 26 Disruptive Technological Advances to Stem Cell Activation
by Joseph Christiano (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Dying Well
Is there a way to talk about death candidly, without fear ... and even with humor? How can we best prepare for it with those we love? This hour, TED speakers explore the beauty of life ... and death. Guests include lawyer Jason Rosenthal, humorist Emily Levine, banker and travel blogger Michelle Knox, mortician Caitlin Doughty, and entrepreneur Lux Narayan.
Now Playing: Science for the People

#492 Flint Water Crisis
This week we dig into the Flint water crisis: what happened, how it got so bad, what turned the tide, what's still left to do, and the mix of science, politics, and activism that are still needed to finish pulling Flint out of the crisis. We spend the hour with Dr Mona Hanna-Attisha, a physician, scientist, activist, the founder and director of the Pediatric Public Health Initiative, and author of the book "What the Eyes Don't See: A Story of Crisis, Resistance, and Hope in an American City".